IL6 and neoplasm: Metastasis tumor, through complex processes involving interleukin (IL)-6, IL-2, and tumor necroting factors (TNF), is hypothesized as a component that involves increasing PCT levels, and found to be not dependent on the type of tumor, except in medullary thyroid carcinoma and neuroendocrine lung tumor [9, 10].